Johnson & Johnson has announced manufacturing, research and development, and technology investments of more than $55bn in the United States over the next four years. This represents a 25% increase in investment compared to the previous four years and builds upon the Company’s already elevated U.S. investment levels resulting from the passage of the 2017…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login

